Download PDF
kleintier konkret 2019; 22(06): 32-44
DOI: 10.1055/a-0947-1094
CVE-Fortbildung
Innere Medizin
Georg Thieme Verlag KG Stuttgart · New York

Canine Parvovirose – Welche Maßnahmen erhöhen die Überlebenschancen?

Frauke Rödler
Further Information

Publication History

Publication Date:
13 December 2019 (online)

Also available at
    Permissions and Reprints All articles of this category

Die Parvovirose verursacht vor allem bei Welpen und Jungtieren schwere Erkrankungs- und Todesfälle. Eine frühzeitige Diagnose und entsprechende adäquate Therapie und konsequente Hygienemaßnahmen können lebensrettend sein und die Verbreitung der Infektion verhindern.
 

  • Literatur

  • 1 Goddard A, Leisewitz AL. Canine parvovirus. Vet Clin North Am Small Anim Pract 2010; 40 (06) 1041-1053
    CrossrefPubMedGoogle Scholar
  • 2 Sykes JE. Canine parvovirus infections and other viral enteritides. In: Sykes JE. Canine and Feline Infectious Diseases. St. Louis, Missouri: Elsevier; 2013
    Google Scholar
  • 3 Markovich JE, Stucker KM, Carr AH. et al. Effects of canine parvovirus strain variations on diagnostic test results and clinical management of enteritis in dogs. J Am Vet Med Assoc 2012; 241 (01) 66-72
    CrossrefPubMedGoogle Scholar
  • 4 Kalli I, Leontides LS, Mylonakis ME. et al. Factors affecting the occurrence, duration of hospitalization and final outcome in canine parvovirus infection. Res Vet Sci 2010; 89 (02) 174-178
    CrossrefPubMedGoogle Scholar
  • 5 Jakel V, Cussler K, Hanschmann KM. et al. Vaccination against feline panleukopenia: implications from a field study in kittens. BMC Vet Rec 2012; 8: 62
    Google Scholar
  • 6 Truyen U. Emergence and recent evolution of canine parvovirus. Vet Microbiol 1999; 69: 47-50
    CrossrefPubMedGoogle Scholar
  • 7 Truyen U, Gruenberg A, Chang SF. et al. Evolution of the feline-subgroup parvoviruses and the control of canine host range in vivo. J Virol 1995; 69 (08) 4702-4710
    CrossrefPubMedGoogle Scholar
  • 8 Greene CE. Feline enteric viral infections. In: Greene CE. ed. Infectious Diseases of the Dog and Cat. 4th ed. St. Louis, Missouri: Elsevier Saunders; 2012: 80-91
    Google Scholar
  • 9 Battilani M, Bassani M, Forti D. et al. Analysis of the evolution of feline parvovirus (FPV). Vet Res Commun 2006; 30 (03) 223-226
    CrossrefGoogle Scholar
  • 10 Truyen U. Evolution of canine parvovirus – a need for new vaccines?. Vet Microbiol 2006; 117 (01) 9-13
    CrossrefPubMedGoogle Scholar
  • 11 Decaro N, Desario C, Miccolupo A. et al. Genetic analysis of feline panleukopenia viruses from cats with gastroenteritis. J Gen Virol 2008; 89 (09) 2290-2298
    CrossrefPubMedGoogle Scholar
  • 12 Hoelzer K, Parrish CR. The emergence of parvoviruses of carnivores. Vet Res 2010; 41 (06) 39
    CrossrefPubMedGoogle Scholar
  • 13 Decaro N, Buonavoglia C. Canine parvovirus – a review of epidemiological and diagnostic aspects, with emphasis on type 2c. Vet Microbiol 2012; 155 (01) 1-12
    CrossrefPubMedGoogle Scholar
  • 14 Carmichael LE. An annotated historical account of canine parvovirus. J Vet Med B Infect Dis Vet Public Health 2005; 52 (7 – 8): 303-311
    CrossrefPubMedGoogle Scholar
  • 15 Martella V, Decaro N, Buonavoglia C. Evolution of CPV-2 and implication for antigenic/genetic characterization. Virus Genes 2006; 33 (01) 11-13
    CrossrefPubMedGoogle Scholar
  • 16 Buonavoglia C, Martella V, Pratelli A. et al. Evidence for evolution of canine parvovirus type 2 in Italy. J Gen Virol 2001; 82 (12) 3021-3025
    CrossrefPubMedGoogle Scholar
  • 17 Decaro N, Martella V, Desario C. et al. First detection of canine parvovirus type 2c in pups with haemorrhagic enteritis in Spain. J Vet Med B Infect Dis Vet Public Health 2006; 53 (10) 468-472
    CrossrefPubMedGoogle Scholar
  • 18 Hong C, Decaro N, Desario C. et al. Occurrence of canine parvovirus type 2c in the United States. J Vet Diagn Invest 2007; 19 (05) 535-539
    CrossrefPubMedGoogle Scholar
  • 19 Pérez R, Francia L, Romero V. et al. First detection of canine parvovirus type 2c in South America. Vet Microbiol 2007; 124 (1 – 2): 147-152
    CrossrefPubMedGoogle Scholar
  • 20 Kapil S, Cooper E, Lamm C. et al. Canine parvovirus types 2c and 2b circulating in North American dogs in 2006 and 2007. J Clin Microbiol 2007; 45 (12) 4044-4047
    CrossrefPubMedGoogle Scholar
  • 21 Ntafis V, Xylouri E, Kalli I. et al. Characterization of canine parvovirus type 2 (CPV-2) variants circulating in Greece. J Vet Diagn Invest 2010; 22 (05) 737-740
    CrossrefPubMedGoogle Scholar
  • 22 Ikeda Y, Nakamura K, Miyazawa T. et al. Feline host range of canine parvovirus: recent emergence of new antigenic types in cats. Emerg Infect Dis 2002; 8 (04) 341-346
    CrossrefPubMedGoogle Scholar
  • 23 Miranda C, Parrish CR, Thompson G. Canine parvovirus 2c infection in a cat with severe clinical disease. J Vet Diagn Invest 2014; 26 (03) 462-464
    CrossrefPubMedGoogle Scholar
  • 24 Decaro N, Buonavoglia D, Desario C. et al. Characterisation of canine parvovirus strains isolated from cats with feline panleukopenia. Res Vet Sci 2010; 89 (02) 275-278
    CrossrefPubMedGoogle Scholar
  • 25 Otto CM, Drobatz KJ, Soter C. Endotoxemia and tumor necrosis factor activity in dogs with naturally occurring parvoviral enteritis. J Vet Intern Med 1997; 11 (02) 65-70
    CrossrefPubMedGoogle Scholar
  • 26 Decaro N, Buonavoglia C. Canine parvovirus – a review of epidemiological and diagnostic aspects, with emphasis on type 2c. Vet Microbiol 2012; 155 (01) 1-12
    CrossrefPubMedGoogle Scholar
  • 27 Decaro N, Campolo M, Desario C. et al. Maternally-derived antibodies in pups and protection from canine parvovirus infection. Biologicals 2005; 33 (04) 261-267
    CrossrefPubMedGoogle Scholar
  • 28 Decaro N, Desario C, Campolo M. et al. Clinical and virological findings in pups naturally infected by canine parvovirus type 2 Glu-426 mutant. J Vet Diagn Invest 2005; 17 (02) 133-138
    CrossrefPubMedGoogle Scholar
  • 29 Smith-Carr S, Macintire DK, Swango LJ. Canine parvovirus. Part I. Pathogenesis and vaccination. Compend Contin Educ Pract Vet 1997; 19 (02) 125-133
    Google Scholar
  • 30 McCaw DL, Hoskins JD. Canine viral enteritis. In: Green CE. ed. Infectious Diseases of the Dog and Cat. 3rd ed. St Louis, Missouri: Saunders; 2006: 63-73
    Google Scholar
  • 31 Turk J, Miller M, Brown T. et al. Coliform septicemia and pulmonary disease associated with canine parvoviral enteritis: 88 cases (1987–1988). J Am Vet Med Assoc 1990; 196 (05) 771-773
    PubMedGoogle Scholar
  • 32 Macintire DK. Bacterial translocation: clinical implications and prevention. In: Bonagure JD. ed. Kirkʼs Current Veterinary Therapy XIII: Small Animal Practice. 13th ed. Philadelphia, PA: Saunders; 2000: 201-203
    Google Scholar
  • 33 Prittie J. Canine parvoviral enteritis: a review of diagnosis, management, and prevention. J Vet Emerg Crit Care 2004; 14 (03) 167-176
    CrossrefGoogle Scholar
  • 34 Yilmaz Z, Senturk S. Characterization of lipid profiles in dogs with parvoviral enteritis. J Small Anim Pract 2007; 48 (11) 643-650
    CrossrefPubMedGoogle Scholar
  • 35 Veir JK. Canine parvoviral enteritis. In: Bonagura JD, Twedt DC. eds. Kirkʼs Current Veterinary Therapy XV. 15th ed. St Louis, Missouri: Elsevier; 2014: 533-535
    Google Scholar
  • 36 Houston DM, Ribble CS, Head LL. Risk factors associated with parvovirus enteritis in dogs: 283 cases (1982–1991). J Am Vet Med Assoc 1996; 208 (04) 542-546
    PubMedGoogle Scholar
  • 37 Proksch AL, Hartmann K. Diagnose der caninen Parvovirus-Infektion. Tieraerztl Prax 2015; 43 (K): 351-357
    Google Scholar
  • 38 Litster AL, Pressler B, Volpe A. et al. Accuracy of a point-of-care ELISA test kit for predicting the presence of protective canine parvovirus and canine distemper virus antibody concentrations in dogs. Vet J 2012; 193 (02) 363-366
    CrossrefPubMedGoogle Scholar
  • 39 Macartney L, McCandlish IA, Thompson H. et al. Canine parvovirus enteritis 1: clinical, haematological and pathological features of experimental infection. Vet Rec 1984; 115 (09) 201-210
    CrossrefPubMedGoogle Scholar
  • 40 Mason MJ, Gillett NA, Muggenburg BA. Clinical, pathological, and epidemiological aspects of canine parvoviral enteritis in an unvaccinated closed Beagle colony: 1978–1985. J Am Anim Hosp Assoc 1987; 23 (02) 183-192
    Google Scholar
  • 41 Macintire DK, Smith-Carr S. Canine parvovirus. Part II. Clinical signs, diagnosis, and treatment. Compend Contin Educ Pract Vet 1997; 19 (03) 291-302
    Google Scholar
  • 42 Rallis TS, Papazoglou LG, Adamama-Moraitou KK. et al. Acute enteritis or gastroenteritis in young dogs as a predisposing factor for intestinal intussusception: a retrospective study. J Vet Med A Physiol Pathol Clin Med 2000; 47 (08) 507-511
    CrossrefPubMedGoogle Scholar
  • 43 Duffy A, Dow S, Ogilvie G. et al. Hematologic improvement in dogs with parvovirus infection treated with recombinant canine granulocyte-colony stimulating factor. J Vet Pharmacol Ther 2010; 33 (04) 352-356
    PubMedGoogle Scholar
  • 44 Greene CE, Decaro N. Canine viral enteritis. In: Greene CE. ed. Infectious Diseases of the Dog and Cat. 4th ed. St Louis, Missouri: Elsevier Saunders; 2012: 67-80
    Google Scholar
  • 45 Goddard A, Leisewitz AL, Christopher MM. et al. Prognostic usefulness of blood leukocyte changes in canine parvoviral enteritis. J Vet Intern Med 2008; 22 (02) 309-316
    CrossrefPubMedGoogle Scholar
  • 46 Brunner CJ, Swango LJ. Canine parvovirus infection: effects on the immune system and factors that predispose to severe disease. Compend Contin Educ Pract Vet 1985; 85: 979-988
    Google Scholar
  • 47 Boosinger TR, Rebar AH, DeNicola DB. et al. Bone marrow alterations associated with canine parvoviral enteritis. Vet Pathol 1982; 19 (05) 558-561
    CrossrefPubMedGoogle Scholar
  • 48 Yilmaz Z, Senturk S. Characterisation of lipid profiles in dogs with parvoviral enteritis. J Small Anim Pract 2007; 48 (11) 643-650
    CrossrefPubMedGoogle Scholar
  • 49 Heald RD, Jones BD, Schmidt DA. Blood gas and electrolyte concentrations in canine parvoviral enteritis. J Am Anim Hosp Assoc 1986; 22 (09) 745-748
    Google Scholar
  • 50 Mann FA, Boon GD, Wagner-Mann CC. et al. Ionized and total magnesium concentrations in blood from dogs with naturally acquired parvoviral enteritis. J Am Vet Med Assoc 1998; 212 (09) 1398-1401
    PubMedGoogle Scholar
  • 51 Kalli IV, Adamama-Moraitou KK, Patsika MN. et al. Prevalence of increased canine pancreas-specific lipase concentrations in young dogs with parvovirus enteritis. Vet Clin Pathol 2017; 46 (01) 111-119
    CrossrefPubMedGoogle Scholar
  • 52 van den Berg MF, Schoeman JP, Defauw P. et al. Assessment of acute kidney injury in canine parvovirus infection: comparison of kidney injury biomarkers with routine renal functional parameters. Vet J 2018; 242: 8-14
    CrossrefPubMedGoogle Scholar
  • 53 McClure V, van Schoor M, Thompson PN. et al. Evaluation of the use of serum C-reactive protein concentration to predict outcome in puppies infected with canine parvovirus. J Am Vet Med Assoc 2013; 243 (03) 361-366
    CrossrefPubMedGoogle Scholar
  • 54 Kocaturk M, Martinez S, Eralp O. et al. Prognostic value of serum acute-phase proteins in dogs with parvoviral enteritis. J Small Anim Pract 2010; 51 (09) 478-483
    CrossrefPubMedGoogle Scholar
  • 55 Kocaturk M, Tvarijonaviciute A, Martinez-Subiela S. et al. Inflammatory and oxidative biomarkers of disease severity in dogs with parvoviral enteritis. J Small Anim Pract 2015; 56 (02) 119-124
    CrossrefPubMedGoogle Scholar
  • 56 Stander N, Wagner WM, Goddard A. et al. Ultrasonographic appearance of canine parvoviral enteritis in puppies. Vet Radiol Ultrasound 2010; 51 (01) 69-74
    CrossrefPubMedGoogle Scholar
  • 57 StIKoVet am Friedrich-Loeffler-Institut. Stellungnahme zur Impfung nach Antikörperbestimmung bei Hund und Katze. Im Internet: http://www.stiko-vet.de Stand: Juni 2019
    Google Scholar
  • 58 Decaro N, Desario C, Beall MJ. et al. Detection of canine parvovirus type 2c by a commercially available in-house rapid test. Vet J 2010; 184 (03) 373-375
    CrossrefPubMedGoogle Scholar
  • 59 Markovich JE, Stucker KM, Carr AH. et al. Effects of canine parvovirus strain variations on diagnostic test results and clinical management of enteritis in dogs. J Am Vet Med Assoc 2012; 241 (01) 66-72
    CrossrefPubMedGoogle Scholar
  • 60 Schmitz S, Coenen C, König M. et al. Comparison of three rapid commercial canine parvovirus antigen detection tests with electron microscopy and polymerase chain reaction. J Vet Diagn Invest 2009; 21 (03) 344-345
    CrossrefPubMedGoogle Scholar
  • 61 Proksch AL, Unterer S, Speck S. et al. Influence of clinical and laboratory variables on faecal antigen ELISA results in dogs with canine parvovirus infection. Vet J 2015; 204 (03) 304-308
    CrossrefPubMedGoogle Scholar
  • 62 Burton JH, Veir J, Morris AK. et al. Detection of canine parvovirus DNA from blood and feces collected from healthy puppies after administration of modified live vaccines. J Vet Intern Med 2008; 22 (03) 703
    Google Scholar
  • 63 Neuerer FF, Horlacher K, Truyen U. et al. Comparison of different in-house test systems to detect parvovirus in faeces of cats. J Feline Med Surg 2008; 10 (03) 247-251
    CrossrefPubMedGoogle Scholar
  • 64 Schunck B, Kraft W, Truyen U. A simple touch-down polymerase chain reaction for the detection of canine parvovirus and feline panleukopenia virus in feces. J Virol Methods 1995; 55 (03) 427-433
    CrossrefPubMedGoogle Scholar
  • 65 Senda M, Hirayama N, Yamamoto H. et al. An improved hemagglutination test for study of canine parvovirus. Vet Microbiol 1986; 12 (01) 1-6
    CrossrefPubMedGoogle Scholar
  • 66 Decaro N, Desario C, Elia G. et al. Occurrence of severe gastroenteritis in pups after canine parvovirus vaccine administration: a clinical and laboratory diagnostic dilemma. Vaccine 2007; 25 (07) 1161-1166
    CrossrefPubMedGoogle Scholar
  • 67 Decaro N, Crescenzo G, Desario C. et al. Long-term viremia and fecal shedding in pups after modified-live canine parvovirus vaccination. Vaccine 2014; 32 (30) 3850-3853
    CrossrefPubMedGoogle Scholar
  • 68 Decaro N, Elia G, Desario C. et al. A minor groove binder probe real-time PCR assay for discrimination between type 2-based vaccines and field strains of canine parvovirus. J Virol Methods 2006; 136 (1 – 2): 65-70
    CrossrefPubMedGoogle Scholar
  • 69 Mohr AJ, Leisewitz AL, Jacobson LS. et al. Effect of early enteral nutrition on intestinal permeability, intestinal protein loss, and outcome in dogs with severe parvoviral enteritis. J Vet Intel Med 2003; 17 (06) 791-798
    Google Scholar
  • 70 Glickman LT, Domanski LM, Patronek GJ. et al. Breed-related risk factors for canine parvovirus enteritis. J Am Vet Med Assoc 1985; 187 (06) 589-594
    PubMedGoogle Scholar
  • 71 Venn EC, Preisner K, Boscan PL. et al. Evaluation of an outpatient protocol in the treatment of canine parvoviral enteritis. J Vet Emerg Crit Care 2017; 27 (01) 52-65
    CrossrefPubMedGoogle Scholar
  • 72 Lobetti RG, Joubert KE, Picard J. et al. Bacterial colonization of intravenous catheters in young dogs suspected to have parvoviral enteritis. J Am Vet Med Assoc 2002; 220 (09) 1321-1324
    CrossrefPubMedGoogle Scholar
  • 73 Lee JA, Cohn LA. Fluid therapy for pediatric patients. Vet Clin North Am Small Anim Pract 2017; 47 (02) 373-382
    CrossrefPubMedGoogle Scholar
  • 74 Macintire D. Pediatric fluid therapy. The Vet Clin North Am Small Animal Prac 2008; 38 (03) 621-627
    Google Scholar
  • 75 DiBartola SP, Autran de Morais H. Disorders of potassium: hypokalemia and hyperkalemia. In: DiBartola SP. ed. Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice. 3rd ed. St Louis, Missouri: Elsevier; 2006: 91-121
    Google Scholar
  • 76 Cazzolli D, Prittie J. The crystalloid-colloid debate: Consequences of resuscitation fluid selection in veterinary critical care. J Vet Emerg Crit Care 2015; 25 (01) 6-19
    CrossrefPubMedGoogle Scholar
  • 77 Erläuterungen zur zweiten Verordnung zur Änderung der Verordnung über Tierärztliche Hausapotheken vom 21. Februar 2018 (BGBl. I S. 213–6). Im Internet: http://www.bundestieraerztekammer.de/btk/dtbl/archiv/artikel/9/2018/Anmerkungen-zur-neuen-TAeHAV Letzter Zugriff: 15.10.2019
    Google Scholar
  • 78 Boscan P, Monnet E, Mama K. et al. Effect of maropitant, a neurokinin 1 receptor antagonist, on anesthetic requirements during noxious visceral stimulation of the ovary in dogs. Am J Vet Res 2011; 72 (12) 1576-1579
    CrossrefPubMedGoogle Scholar
  • 79 Yalcin E, Keser GO. Comparative efficacy of metoclopramide, ondansetron and maropitant in preventing parvoviral enteritis-induced emesis in dogs. J Vet Pharmacol Ther 2017; 40 (06) 599-603
    CrossrefPubMedGoogle Scholar
  • 80 Sullivan LA, Lenberg JP, Boscan P. et al. Assessing the efficacy of maropitant versus ondansetron in the treatment of dogs with parvoviral enteritis. J Am Anim Hosp Assoc 2018; 54 (06) 338-343
    CrossrefPubMedGoogle Scholar
  • 81 Mohr AJ, Leisewitz AL, Jacobson LS. et al. Effect of early enteral nutrition on intestinal permeability, intestinal protein loss, and outcome in dogs with severe parvoviral enteritis. J Vet Intern Med 2003; 17 (06) 791-798
    CrossrefPubMedGoogle Scholar
  • 82 Tenne R, Sullican LA, Contreras ET. et al. Palatability and clinical effects of an oral recuperation fluid during the recovery of dogs with suspected parvoviral enteritis. Top Companion Anim Med 2016; 31 (02) 68-72
    CrossrefPubMedGoogle Scholar
  • 83 De Mari K, Maynard L, Eun HM. et al. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled field trial. Vet Rec 2003; 152 (04) 105-108
    CrossrefPubMedGoogle Scholar
  • 84 Martin V, Najbar W, Gueguen S. et al. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial. Vet Microbiol 2002; 89 (2 – 3): 115-127
    CrossrefPubMedGoogle Scholar
  • 85 Bragg RF, Duffy AL, DeCecco FA. et al. Clinical evaluation of a single dose of immune plasma for treatment of canine parvovirus infection. J Am Vet Med Assoc 2012; 240 (06) 700-704
    CrossrefPubMedGoogle Scholar
  • 86 Meunier PC, Cooper BJ, Appel MJ. et al. Pathogenesis of canine parvovirus enteritis: sequential virus distribution and passive immunization studies. Vet Pathol 1985; 22 (66) 617-624
    CrossrefPubMedGoogle Scholar
  • 87 Gerlach M, Proksch AL, Unterer S. et al. Efficacy of feline anti-parvovirus antibodies in the treatment of canine parvovirus infection. J Small Anim Pract 2017; 58 (07) 408-415
    CrossrefPubMedGoogle Scholar
  • 88 Savigny MR, Macintire DK. Use of oseltamivir in the treatment of canine parvoviral enteritis. J Vet Emerg Crit Care 2010; 20 (01) 132-142
    CrossrefPubMedGoogle Scholar
  • 89 Papaioannou E, Soubasis N, Theodorou K. et al. The potential role of oseltamivir in the management of canine parvoviral enteritis in 50 natural cases. Birmingham, UK: BSAVA Congress; 2013
    Google Scholar
  • 90 Kraft W, Kuffer M. Treatment of severe neutropenias in the dog and cat with filgrastim. Tieraerztl Prax 1995; 23 (06) 609-613
    Google Scholar
  • 91 Rewerts JM, McCaw DL, Cohn LA. et al. Recombinant human granulocyte colony-stimulating factor for treatment of puppies with neutropenia secondary to canine parvovirus infection. J Am Vet Med Assoc 1998; 213 (07) 991-992
    PubMedGoogle Scholar
  • 92 Mischke R, Barth T, Wohlsein P. et al. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on leukocyte count and survival rate of dogs with parvoviral enteritis. Res Vet Sci 2001; 70 (03) 221-225
    CrossrefPubMedGoogle Scholar
  • 93 Henry CJ, Buss MS, Lothrop CD. Veterinary uses of recombinant human granulocyte colony-stimulating factor. Part 1. Oncology. Comp Cont Ed Pract Vet 1998; 20: 728-735
    Google Scholar
  • 94 Duffy A, Dow S, Ogilvie G. et al. Hematologic improvement in dogs with parvovirus infection treated with recombinant canine granulocyte-colony stimulating factor. J Vet Pharmacol Therap 2010; 33 (04) 352-356
    PubMedGoogle Scholar
  • 95 Proksch AL, Unterer S, Truyen U. et al. Efficacy of the paramunity inducer PIND-ORF in the treatment of canine parvovirus infection. Vet J 2014; 202 (02) 340-347
    CrossrefPubMedGoogle Scholar
  • 96 Pereira GQ, Gomes LA, Santos IS. et al. Fecal microbiota transplantation in puppies with canine parvovirus infection. J Vet Intern Med 2018; 32 (02) 707-711
    CrossrefPubMedGoogle Scholar
  • 97 Spibey N, Greenwood NM, Sutton D. et al. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus. Vet Microbiol 2008; 128 (1 – 2): 48-55
    CrossrefPubMedGoogle Scholar
  • 98 Wilson S, Illambas J, Siedek E. et al. Vaccination of dogs with canine parvovirus type 2b (CPV-2b) induces neutralising antibody responses to CPV-2a and CPV-2c. Vaccine 2014; 32 (42) 5420-5424
    CrossrefPubMedGoogle Scholar
  • 99 Ständige Impfkommission Veterinärmedizin am FLI. Leitlinie zur Impfung von Kleintieren. 4. Auf. Im Internet: https://stiko-vet.fli.de/de/stikovet/ Stand: Juni 2019
    Google Scholar
  • 100 Ständige Impfkommission Veterinärmedizin am FLI. Empfehlungen zur guten Impfpraxis in der Veterinärmedizin. Im Internet: https://www.ltk-bw.de/files/LTK-BW/07_Aktuelles/2018-09-26_Stellungnahme_gute_Impfpraxis.pdf Stand: Juni 2019
    Google Scholar
  • 101 Ausschuss der deutschen Veterinärmedizinischen Gesellschaft e.V.. Desinfektion in der Veterinärmedizin. DVG-Desinfektionsmittelliste für die Tierärztliche Praxis und für Tierheime. DVG-Desinfektionsmittelliste für den Tierhaltungsbereich. Im Internet: http://www.desinfektion-dvg.de/index.php?id=2151 Stand: Juni 2019
    Google Scholar